Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fostamatinib (AK106) in Rheumatoid Arthritis
NCT01285752Phase 2Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Feb 2011
- Primary completion
- Jan 2012
- Countries
- 7
01
Overview
A Phase 2 trial of fostamatinib in rheumatoid arthritis (RA), sponsored by Asahi Kasei Corporation. Started Feb 2011; status: completed.
02
Drugs
fostamatinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01285752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285752.